ROOT JONATHAN D
Insider CIK 1225480 · XENT 10% owner · MXL 10% owner · OMED Director, 10% owner · IMI 10% owner · ATRC 10% owner · BOX 10% owner · CSLT 10% owner · GWRE 10% owner · NARI Director, 10% owner · INSP 10% owner · OMDA Director · SBTX Director, 10% owner · EWTX Director · CARL Director · EFTR Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OMDA Omada Health, Inc. | A Award | 2026-10-05 | 2026-10-07 | 694 | — | $0 | 192,571 | SEC↗ |
| OMDA Omada Health, Inc. | A Award | 2026-07-05 | 2026-07-07 | 820 | — | $0 | 191,877 | SEC↗ |
| OMDA Omada Health, Inc. | A Award | 2026-06-16 | 2026-06-18 | 10,882 | — | $0 | 191,057 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2026-06-05 | 2026-07-17 | 16,377 | — | $0 | 16,377 | SEC↗ |
| CARL CARLSMED, INC. | A Award | 2026-06-03 | 2026-06-22 | 13,698 | — | $0 | 497,697 | SEC↗ |
| OMDA Omada Health, Inc. | A Award | 2026-04-05 | 2026-04-07 | 882 | — | $0 | 180,175 | SEC↗ |
| OMDA Omada Health, Inc. | A Award | 2026-01-05 | 2026-01-07 | 915 | — | $0 | 179,293 | SEC↗ |
| OMDA Omada Health, Inc. | J Other | 2025-12-02 | 2025-12-04 | 167,748 | — | $0 | 178,378 | SEC↗ |
| OMDA Omada Health, Inc. | J Other | 2025-12-02 | 2025-12-04 | 4,571,769 | — | $0 | 0 | SEC↗ |
| OMDA Omada Health, Inc. | J Other | 2025-12-02 | 2025-12-04 | 146,257 | — | $0 | 0 | SEC↗ |
| OMDA Omada Health, Inc. | A Award | 2025-10-05 | 2025-10-07 | 657 | — | $0 | 10,630 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion deriv | 2025-07-24 | 2025-07-24 | 2,948,794 | — | $0 | 0 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion deriv | 2025-07-24 | 2025-07-24 | 26,993 | — | $0 | 0 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion deriv | 2025-07-24 | 2025-07-24 | 41,876 | — | $0 | 0 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion deriv | 2025-07-24 | 2025-07-24 | 149,655 | — | $0 | 0 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion deriv | 2025-07-24 | 2025-07-24 | 531,877 | — | $0 | 0 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion deriv | 2025-07-24 | 2025-07-24 | 825,135 | — | $0 | 0 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion deriv | 2025-07-24 | 2025-07-24 | 1,117,743 | — | $0 | 0 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion | 2025-07-24 | 2025-07-24 | 26,993 | — | $0 | 218,524 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion | 2025-07-24 | 2025-07-24 | 1,117,743 | — | $0 | 1,117,743 | SEC↗ |
| CARL CARLSMED, INC. | P Buy | 2025-07-24 | 2025-07-24 | 466,666 | $15.00 | $7.00M | 483,999 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion | 2025-07-24 | 2025-07-24 | 2,948,794 | — | $0 | 2,948,794 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion | 2025-07-24 | 2025-07-24 | 825,135 | — | $0 | 3,773,929 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion | 2025-07-24 | 2025-07-24 | 531,877 | — | $0 | 4,305,806 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion | 2025-07-24 | 2025-07-24 | 149,655 | — | $0 | 149,655 | SEC↗ |
| CARL CARLSMED, INC. | C Conversion | 2025-07-24 | 2025-07-24 | 41,876 | — | $0 | 191,531 | SEC↗ |
| CARL CARLSMED, INC. | A Award | 2025-07-22 | 2025-07-24 | 17,333 | — | $0 | 17,333 | SEC↗ |
| OMDA Omada Health, Inc. | A Award | 2025-07-05 | 2025-07-08 | 237 | — | $0 | 9,973 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2025-06-16 | 2025-06-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| OMDA Omada Health, Inc. | C Conversion deriv | 2025-06-09 | 2025-06-09 | 56,786 | — | $0 | 0 | SEC↗ |
| OMDA Omada Health, Inc. | C Conversion deriv | 2025-06-09 | 2025-06-09 | 357,402 | — | $0 | 0 | SEC↗ |
| OMDA Omada Health, Inc. | C Conversion deriv | 2025-06-09 | 2025-06-09 | 1,775,025 | — | $0 | 0 | SEC↗ |
| OMDA Omada Health, Inc. | C Conversion deriv | 2025-06-09 | 2025-06-09 | 1,813,927 | — | $0 | 0 | SEC↗ |
| OMDA Omada Health, Inc. | C Conversion deriv | 2025-06-09 | 2025-06-09 | 58,030 | — | $0 | 0 | SEC↗ |
| OMDA Omada Health, Inc. | C Conversion deriv | 2025-06-09 | 2025-06-09 | 258,931 | — | $0 | 0 | SEC↗ |
| OMDA Omada Health, Inc. | C Conversion deriv | 2025-06-09 | 2025-06-09 | 11,434 | — | $0 | 0 | SEC↗ |
| OMDA Omada Health, Inc. | C Conversion deriv | 2025-06-09 | 2025-06-09 | 8,283 | — | $0 | 0 | SEC↗ |
| OMDA Omada Health, Inc. | C Conversion deriv | 2025-06-09 | 2025-06-09 | 10,690 | — | $0 | 0 | SEC↗ |
| OMDA Omada Health, Inc. | C Conversion deriv | 2025-06-09 | 2025-06-09 | 334,151 | — | $0 | 0 | SEC↗ |
| OMDA Omada Health, Inc. | C Conversion | 2025-06-09 | 2025-06-09 | 145,223 | — | $0 | 146,257 | SEC↗ |
| OMDA Omada Health, Inc. | C Conversion | 2025-06-09 | 2025-06-09 | 4,539,436 | — | $0 | 4,571,769 | SEC↗ |
| OMDA Omada Health, Inc. | A Award | 2025-06-05 | 2025-06-09 | 9,736 | — | $0 | 9,736 | SEC↗ |
| NARI Inari Medical, Inc. | U Tender | 2025-02-19 | 2025-02-19 | 541,149 | — | $0 | 0 | SEC↗ |
| NARI Inari Medical, Inc. | U Tender | 2025-02-19 | 2025-02-19 | 335 | — | $0 | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2024-06-10 | 2024-06-12 | 20,594 | — | $0 | 20,594 | SEC↗ |
| NARI Inari Medical, Inc. | A Award | 2024-04-24 | 2024-04-26 | 4,126 | $42.41 | $175.0K | 541,149 | SEC↗ |
| NARI Inari Medical, Inc. | A Award | 2024-04-24 | 2024-05-31 | 4,126 | $42.41 | $175.0K | 541,149 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2023-06-12 | 2023-06-14 | 22,123 | — | $0 | 22,123 | SEC↗ |
| NARI Inari Medical, Inc. | M Exercise deriv | 2023-05-27 | 2023-05-30 | 2,982 | — | $0 | 0 | SEC↗ |
| NARI Inari Medical, Inc. | M Exercise | 2023-05-27 | 2023-05-30 | 2,982 | — | $0 | 537,023 | SEC↗ |
| NARI Inari Medical, Inc. | A Award | 2023-05-18 | 2023-05-19 | 2,412 | — | $0 | 534,041 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-08-03 | 2022-08-03 | 1,796 | $0.80 | $1.4K | 127,569 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-08-03 | 2022-08-03 | 57,580 | $0.80 | $46.1K | 3,981,940 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-08-02 | 2022-08-03 | 27,348 | $0.80 | $21.9K | 4,039,520 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-08-02 | 2022-08-03 | 853 | $0.80 | $682 | 129,365 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-08-01 | 2022-08-03 | 807 | $0.79 | $638 | 130,218 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-08-01 | 2022-08-03 | 25,896 | $0.79 | $20.5K | 4,066,868 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-07-28 | 2022-07-29 | 31,533 | $0.89 | $28.1K | 4,092,764 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-07-28 | 2022-07-29 | 984 | $0.89 | $876 | 131,025 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-07-27 | 2022-07-27 | 42,344 | $0.89 | $37.7K | 4,124,297 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-07-27 | 2022-07-27 | 1,321 | $0.89 | $1.2K | 132,009 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-07-26 | 2022-07-27 | 84 | $0.90 | $76 | 133,330 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-07-26 | 2022-07-27 | 2,691 | $0.90 | $2.4K | 4,166,641 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-07-25 | 2022-07-27 | 69 | $0.93 | $64 | 133,414 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-07-25 | 2022-07-27 | 2,210 | $0.93 | $2.1K | 4,169,332 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-07-22 | 2022-07-22 | 7,383 | $0.91 | $6.7K | 4,171,542 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-07-22 | 2022-07-22 | 231 | $0.91 | $210 | 133,483 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-07-21 | 2022-07-22 | 81 | $0.96 | $78 | 133,714 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-07-21 | 2022-07-22 | 2,584 | $0.96 | $2.5K | 4,178,925 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-07-20 | 2022-07-22 | 304 | $1.00 | $304 | 133,795 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-07-20 | 2022-07-22 | 9,726 | $1.00 | $9.7K | 4,181,509 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-07-19 | 2022-07-19 | 2,670 | $1.00 | $2.7K | 4,191,235 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-07-19 | 2022-07-19 | 84 | $1.00 | $84 | 134,099 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-07-18 | 2022-07-19 | 635 | $1.08 | $686 | 134,183 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-07-18 | 2022-07-19 | 20,352 | $1.08 | $22.0K | 4,193,905 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-07-15 | 2022-07-19 | 1,423 | $1.11 | $1.6K | 134,818 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-07-15 | 2022-07-19 | 44,477 | $1.11 | $49.4K | 4,214,257 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2022-06-24 | 2022-06-28 | 42,087 | — | $0 | 42,087 | SEC↗ |
| SBTX Silverback Therapeutics, I | A Award deriv | 2022-06-10 | 2022-06-13 | 18,000 | — | $0 | 18,000 | SEC↗ |
| NARI Inari Medical, Inc. | M Exercise deriv | 2022-05-27 | 2022-05-27 | 2,983 | — | $0 | 2,982 | SEC↗ |
| NARI Inari Medical, Inc. | M Exercise | 2022-05-27 | 2022-05-27 | 2,983 | — | $0 | 531,629 | SEC↗ |
| NARI Inari Medical, Inc. | A Award | 2022-05-26 | 2022-05-27 | 2,420 | — | $0 | 528,646 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-05-19 | 2022-05-19 | 266 | $1.69 | $450 | 136,241 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-05-19 | 2022-05-19 | 8,308 | $1.69 | $14.0K | 4,258,734 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-05-18 | 2022-05-19 | 13,649 | $1.73 | $23.6K | 4,267,042 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-05-18 | 2022-05-19 | 437 | $1.73 | $756 | 136,507 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-05-17 | 2022-05-19 | 365 | $1.75 | $639 | 136,944 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-05-17 | 2022-05-19 | 11,402 | $1.75 | $20.0K | 4,280,691 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-05-16 | 2022-05-16 | 395 | $1.75 | $691 | 137,309 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-05-16 | 2022-05-16 | 12,374 | $1.75 | $21.7K | 4,292,093 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-05-13 | 2022-05-16 | 21,906 | $1.84 | $40.3K | 4,304,467 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-05-13 | 2022-05-16 | 701 | $1.84 | $1.3K | 137,704 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-05-12 | 2022-05-16 | 10,464 | $2.00 | $20.9K | 4,326,373 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-05-12 | 2022-05-16 | 336 | $2.00 | $672 | 138,405 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-05-11 | 2022-05-11 | 4,845 | $2.35 | $11.4K | 4,336,837 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-05-11 | 2022-05-11 | 155 | $2.35 | $364 | 138,741 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-05-10 | 2022-05-11 | 38,743 | $2.41 | $93.4K | 4,341,682 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-05-10 | 2022-05-11 | 1,241 | $2.41 | $3.0K | 138,896 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-05-09 | 2022-05-11 | 124 | $2.54 | $315 | 140,137 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2022-05-09 | 2022-05-11 | 3,876 | $2.54 | $9.8K | 4,380,425 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | J Other | 2022-02-25 | 2022-02-28 | 3,473,543 | — | $0 | 0 | SEC↗ |
| SBTX Silverback Therapeutics, I | J Other | 2021-12-13 | 2021-12-15 | 2,069,167 | — | $0 | 0 | SEC↗ |
| SBTX Silverback Therapeutics, I | J Other | 2021-12-13 | 2021-12-15 | 105,012 | — | $0 | 0 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-12-02 | 2021-12-06 | 252 | $5.68 | $1.4K | 140,261 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-12-02 | 2021-12-06 | 7,861 | $5.68 | $44.7K | 4,384,301 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-12-01 | 2021-12-01 | 597 | $6.44 | $3.8K | 140,513 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-12-01 | 2021-12-01 | 18,648 | $6.44 | $120.1K | 4,392,162 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-30 | 2021-12-01 | 850 | $6.53 | $5.6K | 141,110 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-30 | 2021-12-01 | 26,559 | $6.53 | $173.4K | 4,410,810 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-29 | 2021-12-01 | 24,965 | $6.70 | $167.3K | 4,437,369 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-29 | 2021-12-01 | 799 | $6.70 | $5.4K | 141,960 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-26 | 2021-11-26 | 4,870 | $7.01 | $34.1K | 4,462,334 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-26 | 2021-11-26 | 156 | $7.01 | $1.1K | 142,759 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-24 | 2021-11-26 | 35,388 | $7.36 | $260.5K | 4,467,204 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-24 | 2021-11-26 | 1,132 | $7.36 | $8.3K | 142,915 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-23 | 2021-11-26 | 461 | $7.40 | $3.4K | 144,047 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-23 | 2021-11-26 | 14,418 | $7.40 | $106.7K | 4,502,592 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-22 | 2021-11-22 | 812 | $7.86 | $6.4K | 144,508 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-22 | 2021-11-22 | 25,371 | $7.86 | $199.4K | 4,517,010 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-19 | 2021-11-22 | 224 | $8.12 | $1.8K | 145,320 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-19 | 2021-11-22 | 7,017 | $8.12 | $57.0K | 4,542,381 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-18 | 2021-11-22 | 16,226 | $8.53 | $138.4K | 4,549,398 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-18 | 2021-11-22 | 519 | $8.53 | $4.4K | 145,544 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-17 | 2021-11-17 | 317 | $9.13 | $2.9K | 146,063 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-17 | 2021-11-17 | 9,918 | $9.13 | $90.6K | 4,565,624 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-16 | 2021-11-17 | 257 | $9.42 | $2.4K | 146,380 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-16 | 2021-11-17 | 8,062 | $9.42 | $75.9K | 4,575,542 | SEC↗ |
| NARI Inari Medical, Inc. | P Buy | 2021-11-15 | 2022-03-18 | 303 | $89.08 | $27.0K | 335 | SEC↗ |
| SBTX Silverback Therapeutics, I | P Buy | 2021-11-15 | 2022-03-18 | 2,014 | $8.85 | $17.8K | 2,364 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-15 | 2021-11-17 | 157 | $9.81 | $1.5K | 146,637 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-15 | 2021-11-17 | 4,914 | $9.81 | $48.2K | 4,583,604 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-12 | 2021-11-12 | 11,628 | $10.07 | $117.1K | 4,588,518 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-12 | 2021-11-12 | 372 | $10.07 | $3.7K | 146,794 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-11 | 2021-11-12 | 373 | $10.37 | $3.9K | 147,166 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-11 | 2021-11-12 | 11,644 | $10.37 | $120.7K | 4,600,146 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-10 | 2021-11-12 | 1,054 | $10.44 | $11.0K | 147,539 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-10 | 2021-11-12 | 32,946 | $10.44 | $344.0K | 4,611,790 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-09 | 2021-11-12 | 27,892 | $11.00 | $306.8K | 4,644,736 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | S Sale | 2021-11-09 | 2021-11-12 | 893 | $11.00 | $9.8K | 148,593 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2021-10-06 | 2021-10-08 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2021-08-25 | 2021-08-27 | 18,765 | — | $0 | 18,765 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2021-08-25 | 2021-08-27 | 586,573 | — | $0 | 586,573 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award | 2021-08-25 | 2021-08-27 | 690,688 | $10.00 | $6.91M | 4,672,628 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award | 2021-08-25 | 2021-08-27 | 3,981,940 | — | $0 | 3,981,940 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award | 2021-08-25 | 2021-08-27 | 22,097 | $10.00 | $221.0K | 149,486 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award | 2021-08-25 | 2021-08-27 | 127,389 | — | $0 | 127,389 | SEC↗ |
| SBTX Silverback Therapeutics, I | A Award deriv | 2021-06-04 | 2021-09-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NARI Inari Medical, Inc. | M Exercise deriv | 2021-05-27 | 2021-05-28 | 2,982 | — | $0 | 5,965 | SEC↗ |
| NARI Inari Medical, Inc. | M Exercise | 2021-05-27 | 2021-05-28 | 2,982 | — | $0 | 524,846 | SEC↗ |
| NARI Inari Medical, Inc. | A Award | 2021-05-27 | 2021-05-28 | 1,380 | — | $0 | 526,226 | SEC↗ |
| NARI Inari Medical, Inc. | J Other | 2021-05-13 | 2021-05-17 | 685,826 | — | $0 | 685,826 | SEC↗ |
| NARI Inari Medical, Inc. | J Other | 2021-05-13 | 2021-05-17 | 685,826 | — | $0 | 0 | SEC↗ |
| NARI Inari Medical, Inc. | J Other | 2021-05-13 | 2021-05-17 | 93,972 | — | $0 | 521,864 | SEC↗ |
| NARI Inari Medical, Inc. | J Other | 2021-05-13 | 2021-05-17 | 83,813 | — | $0 | 0 | SEC↗ |
| NARI Inari Medical, Inc. | J Other | 2021-05-13 | 2021-05-17 | 2,619,872 | — | $0 | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | C Conversion deriv | 2021-03-30 | 2021-03-31 | 455,229 | — | $0 | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | C Conversion deriv | 2021-03-30 | 2021-03-31 | 1,651,607 | — | $0 | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | C Conversion deriv | 2021-03-30 | 2021-03-31 | 1,366,707 | — | $0 | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | C Conversion | 2021-03-30 | 2021-03-31 | 3,473,543 | — | $0 | 3,473,543 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | P Buy | 2021-03-30 | 2021-03-31 | 15,625 | $16.00 | $250.0K | 15,625 | SEC↗ |
| NARI Inari Medical, Inc. | J Other | 2021-03-16 | 2021-03-18 | 83,814 | — | $0 | 83,813 | SEC↗ |
| NARI Inari Medical, Inc. | J Other | 2021-03-16 | 2021-03-18 | 2,619,872 | — | $0 | 2,619,872 | SEC↗ |
| NARI Inari Medical, Inc. | J Other | 2021-03-16 | 2021-03-18 | 94,101 | — | $0 | 427,892 | SEC↗ |
| NARI Inari Medical, Inc. | J Other | 2021-03-16 | 2021-03-18 | 685,827 | — | $0 | 0 | SEC↗ |
| NARI Inari Medical, Inc. | J Other | 2021-03-16 | 2021-03-18 | 685,827 | — | $0 | 685,827 | SEC↗ |
| SBTX Silverback Therapeutics, I | P Buy | 2021-03-03 | 2022-03-18 | 350 | $52.07 | $18.2K | 350 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion deriv | 2020-12-08 | 2020-12-08 | 335,417 | — | $0 | 0 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion deriv | 2020-12-08 | 2020-12-08 | 1,073,793 | — | $0 | 0 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion deriv | 2020-12-08 | 2020-12-08 | 54,496 | — | $0 | 0 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion deriv | 2020-12-08 | 2020-12-08 | 6,609,027 | — | $0 | 0 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion | 2020-12-08 | 2020-12-08 | 289,198 | — | $0 | 2,069,167 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion | 2020-12-08 | 2020-12-08 | 90,335 | — | $0 | 90,335 | SEC↗ |
| SBTX Silverback Therapeutics, I | P Buy | 2020-12-08 | 2020-12-08 | 95,238 | $21.00 | $2.00M | 95,238 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion | 2020-12-08 | 2020-12-08 | 1,779,969 | — | $0 | 1,779,969 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion | 2020-12-08 | 2020-12-08 | 14,677 | — | $0 | 105,012 | SEC↗ |
| SBTX Silverback Therapeutics, I | A Award deriv | 2020-12-03 | 2020-12-07 | 38,270 | — | $0 | 38,270 | SEC↗ |
| NARI Inari Medical, Inc. | J Other | 2020-11-17 | 2021-01-21 | 81,996 | — | $0 | 333,791 | SEC↗ |
| NARI Inari Medical, Inc. | J Other | 2020-11-17 | 2020-11-19 | 81,996 | — | $0 | 81,996 | SEC↗ |
| NARI Inari Medical, Inc. | J Other | 2020-11-17 | 2020-11-19 | 587,851 | — | $0 | 0 | SEC↗ |
| NARI Inari Medical, Inc. | J Other | 2020-11-17 | 2020-11-19 | 2,245,605 | — | $0 | 5,239,744 | SEC↗ |
| NARI Inari Medical, Inc. | J Other | 2020-11-17 | 2020-11-19 | 587,851 | — | $0 | 587,851 | SEC↗ |
| NARI Inari Medical, Inc. | J Other | 2020-11-17 | 2020-11-19 | 71,840 | — | $0 | 167,627 | SEC↗ |
| NARI Inari Medical, Inc. | P Buy | 2020-06-22 | 2022-03-18 | 32 | $46.61 | $1.5K | 32 | SEC↗ |
| NARI Inari Medical, Inc. | C Conversion deriv | 2020-05-27 | 2020-05-27 | 2,307,142 | — | $0 | 0 | SEC↗ |
| NARI Inari Medical, Inc. | C Conversion deriv | 2020-05-27 | 2020-05-27 | 73,809 | — | $0 | 0 | SEC↗ |
| NARI Inari Medical, Inc. | C Conversion deriv | 2020-05-27 | 2020-05-27 | 2,899,876 | — | $0 | 0 | SEC↗ |
| NARI Inari Medical, Inc. | C Conversion deriv | 2020-05-27 | 2020-05-27 | 2,278,331 | — | $0 | 0 | SEC↗ |
| NARI Inari Medical, Inc. | C Conversion deriv | 2020-05-27 | 2020-05-27 | 72,887 | — | $0 | 0 | SEC↗ |
| NARI Inari Medical, Inc. | C Conversion deriv | 2020-05-27 | 2020-05-27 | 92,771 | — | $0 | 0 | SEC↗ |
| NARI Inari Medical, Inc. | A Award deriv | 2020-05-27 | 2020-05-27 | 8,947 | — | $0 | 8,947 | SEC↗ |
| NARI Inari Medical, Inc. | P Buy | 2020-05-27 | 2020-05-27 | 251,795 | $19.00 | $4.78M | 251,795 | SEC↗ |
| NARI Inari Medical, Inc. | C Conversion | 2020-05-27 | 2020-05-27 | 7,485,349 | — | $0 | 7,485,349 | SEC↗ |
| NARI Inari Medical, Inc. | C Conversion | 2020-05-27 | 2020-05-27 | 239,467 | — | $0 | 239,467 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | U Tender | 2019-04-23 | 2019-04-23 | 121,020 | — | $0 | 0 | SEC↗ |
| IMI INTERMOLECULAR INC | S Sale | 2018-11-13 | 2018-11-13 | 2,400 | $0.95 | $2.3K | 97,593 | SEC↗ |
| IMI INTERMOLECULAR INC | S Sale | 2018-11-12 | 2018-11-13 | 2,100 | $0.96 | $2.0K | 99,993 | SEC↗ |
| IMI INTERMOLECULAR INC | J Other | 2018-11-08 | 2018-11-13 | 102,093 | — | $0 | 102,093 | SEC↗ |
| IMI INTERMOLECULAR INC | J Other | 2018-11-08 | 2018-11-13 | 4,280,779 | — | $0 | 0 | SEC↗ |
| IMI INTERMOLECULAR INC | J Other | 2018-11-08 | 2018-11-13 | 856,155 | — | $0 | 856,155 | SEC↗ |
| IMI INTERMOLECULAR INC | J Other | 2018-11-08 | 2018-11-13 | 856,155 | — | $0 | 0 | SEC↗ |
| IMI INTERMOLECULAR INC | J Other | 2018-11-08 | 2018-11-13 | 82,370 | — | $0 | 82,370 | SEC↗ |
| IMI INTERMOLECULAR INC | J Other | 2018-11-08 | 2018-11-13 | 60,336 | — | $0 | 60,336 | SEC↗ |
| IMI INTERMOLECULAR INC | J Other | 2018-11-08 | 2018-11-13 | 85,851 | — | $0 | 85,851 | SEC↗ |
| IMI INTERMOLECULAR INC | J Other | 2018-11-08 | 2018-11-13 | 60,408 | — | $0 | 60,408 | SEC↗ |
| IMI INTERMOLECULAR INC | J Other | 2018-11-08 | 2018-11-13 | 69,609 | — | $0 | 69,609 | SEC↗ |
| INSP Inspire Medical Systems, I | J Other | 2018-11-08 | 2018-11-13 | 1,084,127 | — | $0 | 1,084,127 | SEC↗ |
| INSP Inspire Medical Systems, I | J Other | 2018-11-08 | 2018-11-13 | 15,391 | — | $0 | 15,391 | SEC↗ |
| INSP Inspire Medical Systems, I | J Other | 2018-11-08 | 2018-11-13 | 22,573 | — | $0 | 22,573 | SEC↗ |
| INSP Inspire Medical Systems, I | J Other | 2018-11-08 | 2018-11-13 | 18,212 | — | $0 | 18,212 | SEC↗ |
| INSP Inspire Medical Systems, I | J Other | 2018-11-08 | 2018-11-13 | 216,825 | — | $0 | 0 | SEC↗ |
| INSP Inspire Medical Systems, I | J Other | 2018-11-08 | 2018-11-13 | 18,982 | — | $0 | 18,982 | SEC↗ |
| INSP Inspire Medical Systems, I | J Other | 2018-11-08 | 2018-11-13 | 13,356 | — | $0 | 13,356 | SEC↗ |
| INSP Inspire Medical Systems, I | J Other | 2018-11-08 | 2018-11-13 | 216,825 | — | $0 | 216,825 | SEC↗ |
| INSP Inspire Medical Systems, I | J Other | 2018-11-08 | 2018-11-13 | 18,212 | — | $0 | 18,212 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2018-06-22 | 2018-06-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| INSP Inspire Medical Systems, I | C Conversion deriv | 2018-05-07 | 2018-05-09 | 948,855 | — | $0 | 0 | SEC↗ |
| INSP Inspire Medical Systems, I | C Conversion deriv | 2018-05-07 | 2018-05-09 | 3,142,670 | — | $0 | 0 | SEC↗ |
| INSP Inspire Medical Systems, I | C Conversion deriv | 2018-05-07 | 2018-05-09 | 2,102,315 | — | $0 | 0 | SEC↗ |
| INSP Inspire Medical Systems, I | C Conversion deriv | 2018-05-07 | 2018-05-09 | 3,795,620 | — | $0 | 0 | SEC↗ |
| INSP Inspire Medical Systems, I | C Conversion deriv | 2018-05-07 | 2018-05-09 | 2,400,000 | — | $0 | 0 | SEC↗ |
| INSP Inspire Medical Systems, I | C Conversion deriv | 2018-05-07 | 2018-05-09 | 1,397,478 | — | $0 | 0 | SEC↗ |
| INSP Inspire Medical Systems, I | C Conversion | 2018-05-07 | 2018-05-09 | 360,902 | — | $0 | 360,902 | SEC↗ |
| INSP Inspire Medical Systems, I | C Conversion | 2018-05-07 | 2018-05-09 | 570,769 | — | $0 | 2,168,254 | SEC↗ |
| INSP Inspire Medical Systems, I | C Conversion | 2018-05-07 | 2018-05-09 | 163,962 | — | $0 | 1,597,485 | SEC↗ |
| INSP Inspire Medical Systems, I | C Conversion | 2018-05-07 | 2018-05-09 | 210,147 | — | $0 | 1,433,523 | SEC↗ |
| INSP Inspire Medical Systems, I | C Conversion | 2018-05-07 | 2018-05-09 | 472,581 | — | $0 | 1,223,376 | SEC↗ |
| INSP Inspire Medical Systems, I | C Conversion | 2018-05-07 | 2018-05-09 | 389,893 | — | $0 | 750,795 | SEC↗ |
| BOX BOX INC | C Conversion deriv | 2017-06-02 | 2017-06-05 | 8,000,000 | — | $0 | 3,713,775 | SEC↗ |
| BOX BOX INC | C Conversion deriv | 2017-06-02 | 2017-06-08 | 8,000,000 | — | $0 | 3,713,775 | SEC↗ |
| BOX BOX INC | J Other | 2017-06-02 | 2017-06-05 | 8,000,000 | — | $0 | 0 | SEC↗ |
| BOX BOX INC | C Conversion | 2017-06-02 | 2017-06-05 | 8,000,000 | — | $0 | 8,000,000 | SEC↗ |
| BOX BOX INC | C Conversion | 2017-06-02 | 2017-06-08 | 8,000,000 | — | $0 | 8,000,000 | SEC↗ |
| BOX BOX INC | J Other | 2017-06-02 | 2017-06-08 | 8,000,000 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2017-06-01 | 2017-06-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2017-05-26 | 2017-05-26 | 6,358 | $3.70 | $23.5K | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2017-05-26 | 2017-05-26 | 3,222 | $3.70 | $11.9K | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2017-05-24 | 2017-05-26 | 2,853 | $3.72 | $10.6K | 6,358 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2017-05-24 | 2017-05-26 | 1,447 | $3.72 | $5.4K | 3,222 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2017-05-19 | 2017-05-22 | 4,968 | $3.70 | $18.4K | 9,211 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2017-05-19 | 2017-05-22 | 2,519 | $3.70 | $9.3K | 4,669 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2017-05-16 | 2017-05-18 | 4,579 | $3.58 | $16.4K | 14,179 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2017-05-16 | 2017-05-18 | 2,321 | $3.58 | $8.3K | 7,188 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2017-05-11 | 2017-05-15 | 55,929 | — | $0 | 121,020 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2017-05-11 | 2017-05-15 | 1,990,783 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2017-05-11 | 2017-05-15 | 19,215 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2016-06-22 | 2016-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-11-30 | 2015-12-02 | 429 | — | $0 | 65,091 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2015-06-19 | 2015-06-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XENT Intersect ENT, Inc. | J Other | 2015-05-08 | 2015-05-11 | 990,000 | — | $0 | 1,995,433 | SEC↗ |
| XENT Intersect ENT, Inc. | J Other | 2015-03-02 | 2015-03-06 | 990,000 | — | $0 | 2,985,433 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-02-24 | 2015-02-26 | 712 | — | $0 | 64,662 | SEC↗ |
| BOX BOX INC | C Conversion deriv | 2015-01-28 | 2015-01-30 | 8,283,181 | — | $0 | 0 | SEC↗ |
| BOX BOX INC | C Conversion deriv | 2015-01-28 | 2015-01-30 | 2,486,922 | — | $0 | 0 | SEC↗ |
| BOX BOX INC | C Conversion deriv | 2015-01-28 | 2015-01-30 | 943,672 | — | $0 | 0 | SEC↗ |
| BOX BOX INC | J Other deriv | 2015-01-28 | 2015-01-30 | 11,713,775 | — | $0 | 11,713,775 | SEC↗ |
| BOX BOX INC | J Other | 2015-01-28 | 2015-01-30 | 11,713,775 | — | $0 | 0 | SEC↗ |
| BOX BOX INC | C Conversion | 2015-01-28 | 2015-01-30 | 11,713,775 | — | $0 | 11,713,775 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-01-09 | 2015-01-13 | 712 | — | $0 | 63,950 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-12-18 | 2014-12-19 | 4,390 | $21.05 | $92.4K | 9,509 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-12-18 | 2014-12-19 | 8,662 | $21.05 | $182.3K | 18,758 | SEC↗ |
| CSLT CASTLIGHT HEALTH, INC. | C Conversion | 2014-09-09 | 2014-09-10 | 1,170,392 | — | $0 | 1,170,392 | SEC↗ |
| CSLT CASTLIGHT HEALTH, INC. | C Conversion | 2014-09-09 | 2014-09-10 | 37,443 | — | $0 | 37,443 | SEC↗ |
| CSLT CASTLIGHT HEALTH, INC. | C Conversion | 2014-09-09 | 2014-09-10 | 37,443 | — | $0 | 37,443 | SEC↗ |
| CSLT CASTLIGHT HEALTH, INC. | J Other | 2014-09-09 | 2014-09-10 | 1,170,392 | — | $0 | 0 | SEC↗ |
| CSLT CASTLIGHT HEALTH, INC. | J Other | 2014-09-09 | 2014-09-10 | 37,443 | — | $0 | 0 | SEC↗ |
| CSLT CASTLIGHT HEALTH, INC. | C Conversion | 2014-09-09 | 2014-09-10 | 1,170,392 | — | $0 | 1,170,392 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-08-08 | 2014-08-12 | 30,846 | — | $0 | 63,238 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-08-08 | 2014-08-12 | 9,046 | — | $0 | 19,215 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-08-08 | 2014-08-12 | 937,205 | — | $0 | 1,990,783 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-08-08 | 2014-08-12 | 285,734 | — | $0 | 285,734 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-08-08 | 2014-08-12 | 285,734 | — | $0 | 0 | SEC↗ |
| XENT Intersect ENT, Inc. | C Conversion deriv | 2014-07-29 | 2014-07-30 | 746,054 | — | $0 | 0 | SEC↗ |
| XENT Intersect ENT, Inc. | C Conversion deriv | 2014-07-29 | 2014-07-30 | 1,120,129 | — | $0 | 0 | SEC↗ |
| XENT Intersect ENT, Inc. | C Conversion deriv | 2014-07-29 | 2014-07-30 | 817,034 | — | $0 | 0 | SEC↗ |
| XENT Intersect ENT, Inc. | C Conversion deriv | 2014-07-29 | 2014-07-30 | 1,292,216 | — | $0 | 0 | SEC↗ |
| XENT Intersect ENT, Inc. | C Conversion | 2014-07-29 | 2014-07-30 | 817,034 | — | $0 | 1,937,163 | SEC↗ |
| XENT Intersect ENT, Inc. | C Conversion | 2014-07-29 | 2014-07-30 | 1,292,216 | — | $0 | 3,229,379 | SEC↗ |
| XENT Intersect ENT, Inc. | C Conversion | 2014-07-29 | 2014-07-30 | 746,054 | — | $0 | 3,975,433 | SEC↗ |
| XENT Intersect ENT, Inc. | C Conversion | 2014-07-29 | 2014-07-30 | 1,120,129 | — | $0 | 1,120,129 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2014-06-18 | 2014-06-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-06-10 | 2014-06-11 | 3,186 | $24.48 | $78.0K | 21,944 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-06-10 | 2014-06-11 | 1,614 | $24.48 | $39.5K | 11,123 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-06-09 | 2014-06-11 | 5,476 | $24.62 | $134.8K | 30,606 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-06-09 | 2014-06-11 | 2,776 | $24.62 | $68.3K | 15,513 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-05-09 | 2014-05-13 | 300,063 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-05-09 | 2014-05-13 | 975,996 | — | $0 | 2,927,988 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-05-09 | 2014-05-13 | 9,421 | — | $0 | 28,261 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-05-09 | 2014-05-13 | 32,392 | — | $0 | 32,392 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-05-09 | 2014-05-13 | 300,063 | — | $0 | 300,063 | SEC↗ |
| CSLT CASTLIGHT HEALTH, INC. | C Conversion deriv | 2014-03-19 | 2014-03-20 | 1,639 | — | $0 | 0 | SEC↗ |
| CSLT CASTLIGHT HEALTH, INC. | C Conversion deriv | 2014-03-19 | 2014-03-20 | 4,170 | — | $0 | 0 | SEC↗ |
| CSLT CASTLIGHT HEALTH, INC. | C Conversion deriv | 2014-03-19 | 2014-03-20 | 489,752 | — | $0 | 0 | SEC↗ |
| CSLT CASTLIGHT HEALTH, INC. | C Conversion deriv | 2014-03-19 | 2014-03-20 | 1,649,919 | — | $0 | 0 | SEC↗ |
| CSLT CASTLIGHT HEALTH, INC. | C Conversion deriv | 2014-03-19 | 2014-03-20 | 52,784 | — | $0 | 0 | SEC↗ |
| CSLT CASTLIGHT HEALTH, INC. | C Conversion deriv | 2014-03-19 | 2014-03-20 | 15,668 | — | $0 | 0 | SEC↗ |
| CSLT CASTLIGHT HEALTH, INC. | C Conversion deriv | 2014-03-19 | 2014-03-20 | 51,223 | — | $0 | 0 | SEC↗ |
| CSLT CASTLIGHT HEALTH, INC. | C Conversion deriv | 2014-03-19 | 2014-03-20 | 130,339 | — | $0 | 0 | SEC↗ |
| CSLT CASTLIGHT HEALTH, INC. | C Conversion | 2014-03-19 | 2014-03-20 | 74,261 | — | $0 | 74,886 | SEC↗ |
| CSLT CASTLIGHT HEALTH, INC. | C Conversion | 2014-03-19 | 2014-03-20 | 2,321,233 | — | $0 | 2,340,784 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 9,505 | — | $0 | 0 | SEC↗ |